Search results for "Highlights"


 
Results 21 - 30 of about 67 for "Highlights".

Highlights

A retrospective cohort study looked at patients with cirrhosis who were enrolled in Medicare and had had more than four outpatient visits over 180 days.
January 2020

Probiotics reduce C. difficile in hospitalized patients on antibiotics, review finds

In 19 randomized controlled trials of 6,261 hospitalized patients on antibiotics, the incidence of C. difficile was 1.6% among patients taking probiotics compared to 3.9% in controls.
February 2017

Highlights

Testing for Clostridioides difficile at one Wisconsin hospital found higher risk for colonization among hematology-oncology patients but an association of residential proximity to livestock farms and colonization only among patients admitted to
January 2020

Guideline recommends standardized management of mild to moderate ulcerative colitis

The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
December 2018

Combination therapy for IBD carries higher infection risk than monotherapy

Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a
March 2019

Individual or group hypnotherapy associated with relief from IBS

Although hypnotherapy did not improve quality of life, psychological symptoms, cognition, self-efficacy, or irritable bowel syndrome (IBS) symptoms significantly more than an educational support program, it may provide relief to patients by changing
December 2018

Previous gastroenteritis may be associated with later risk for IBD

In this Swedish case-control study, any previous GI infection and previous bacterial, parasitic, and viral GI infection were associated with higher risk for inflammatory bowel disease (IBD) versus controls.
November 2018

Highlights

There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
May 2019

8 weeks of ledipasvir/sofosbuvir may be effective for genotype 1 hepatitis C

The therapy should be considered in patients with genotype 1 infection who are treatment-naive, do not have cirrhosis, and have a pretreatment viral load below 6,000,000 IU/mL, a study found.
March 2017

Guideline released on treatment of Helicobacter pylori infection

Clarithromycin triple therapy should be used for first-line treatment of Helicobacter pylori infection only in patients with no history of macrolide exposure who live in areas where H. pylori resistance to clarithromycin is known to be low, among
January 2017

Result Page: Prev   1   2   3   4   5   6   7   Next